Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma
A pseudogene pair-based survival prediction model for HNSCC was developed and validated, providing valuable insights for HNSCC treatment. LAT may serve as a novel biomarker for predicting immune response.
Authors
- Xiaochuan Chen (ORCID: https://orcid.org/0000-0003-3901-0524)
- Guanghao Chen (ORCID: https://orcid.org/0000-0002-1353-8585)
- Xinyi Hong (ORCID: https://orcid.org/0000-0001-5563-6055)
- Sufang Qiu (ORCID: https://orcid.org/0000-0001-7660-6955)
- Wenquan Hong
- Qin Ding
- Jinghua Lai (ORCID: https://orcid.org/0009-0005-4528-7564)
- Jun Lu (ORCID: https://orcid.org/0000-0002-0407-3835)
- Ting Lin (ORCID: https://orcid.org/0000-0002-7463-8408)
- Wenqian Xu (ORCID: https://orcid.org/0000-0003-4962-3295)
- Hanxuan Yang
Institutions
- Fujian Medical University (CN)
- Longyan University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1007/s12672-025-03316-2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province